HOTAIR mediates cisplatin resistance in nasopharyngeal carcinoma by regulating miR-106a-5p/SOX4 axis

References

• Lee AWM, Ng WT, Chan JYW, et al. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev. 2019;79:101890.
   PubMed Web of Science ®Google Scholar
• Sun XS, Li XY, Chen QY, et al. Future of radiotherapy in nasopharyngeal carcinoma. Br J Radiol. 2019;92:20190209.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen L, and Hu G-Q, et al. Gemcitabine and Cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019;381:1124–1135.
   PubMed Web of Science ®Google Scholar
• Altundag K, Aksoy S, Gullu I, et al. Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy. Med Oncol. 2004;21:211–215.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Shinjo K, Katsushima K. Long non-coding RNAs as an epigenetic regulator in human cancers. Cancer Sci. 2017;108:1927–1933.
   PubMed Web of Science ®Google Scholar
• Beermann J, Piccoli MT, Viereck J, et al. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96:1297–1325.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155–159.
   PubMed Web of Science ®Google Scholar
• Qu X, Alsager S, Zhuo Y, et al. HOX transcript antisense RNA (HOTAIR) in cancer. Cancer Lett. 2019;454:90–97.
   PubMed Web of Science ®Google Scholar
• Zhao W, Geng D, and Li S, et al. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med . 2018;7:842–855.
   PubMed Web of Science ®Google Scholar
• Loewen G, Jayawickramarajah J, Zhuo Y, et al. Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014;7(1):90.
   PubMed Web of Science ®Google Scholar
• Yang L, Peng X, Li Y, et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol Cancer. 2019;18(1):78.
   PubMedGoogle Scholar
• Guo F, Cao Z, Guo H, et al. The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway. Exp Ther Med. 2018;15:4885–4889.
   PubMed Web of Science ®Google Scholar
• Poel D, Boyd LNC, and Beekhof R. Proteomic analysis of miR-195 and miR-497 replacement reveals potential candidates that increase sensitivity to oxaliplatin in MSI/P53wt colorectal cancer cells. Cells. 8(9): 1111. (2019).
   PubMed Web of Science ®Google Scholar
• Xu T, Yu W, Li Q, et al. MicroRNA-524 inhibits the progress of glioma via the direct targeting of NCF2. Am J Transl Res. 2019;11:1605–1615.
   PubMed Web of Science ®Google Scholar
• Chang H, Li J, Qu K, et al. CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NFκB pathway in hepatocellular carcinoma. Cell Death Dis. 2020;11(5):332.
   PubMed Web of Science ®Google Scholar
• Chen X, Lu P, Wang D-D, et al. The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues. Gene. 2016;595(2):221–226.
   PubMed Web of Science ®Google Scholar
• Zheng YJ, Zhao J-Y, Liang T-S, et al. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma. FASEB J. 2019;33:12915–12928.
   PubMed Web of Science ®Google Scholar
• Wu J, Huang J, Wang W, et al. Long non-coding RNA Fer-1-like protein 4 acts as a tumor suppressor via miR-106a-5p and predicts good prognosis in hepatocellular carcinoma. Cancer Biomark. 2017;20(1):55–65.
   PubMed Web of Science ®Google Scholar
• Yue B, Sun B, Liu C, et al. Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer. Cancer Sci. 2015;106(10):1323–1332.
   PubMed Web of Science ®Google Scholar
• Moreno CS. SOX4: the unappreciated oncogene. Semin Cancer Biol. 2019. DOI:10.1016/j.semcancer.2019.08.027
   PubMed Web of Science ®Google Scholar
• Hanieh H, Ahmed EA, Vishnubalaji R, et al. SOX4: epigenetic regulation and role in tumorigenesis. Semin Cancer Biol. 2019. DOI:10.1016/j.semcancer.2019.06.022
   PubMed Web of Science ®Google Scholar
• Miao X, Deng Z, Wang S, et al. IAP-1 promoted cisplatin resistance in nasopharyngeal carcinoma via inhibition of caspase-3-mediated apoptosis. Am J Cancer Res. 2021;11:640–667.
   PubMed Web of Science ®Google Scholar
• Ma BBY, Lui VWY, Hui EP, et al. The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines. Invest New Drugs. 2010;28:413–420.
   PubMed Web of Science ®Google Scholar
• Chen S, Cheng A-C, Wang M-S, et al. Detection of apoptosis induced by new type gosling viral enteritis virus in vitro through fluorescein annexin V-FITC/PI double labeling. World J Gastroenterol. 2008;14(14):2174–2178.
   PubMed Web of Science ®Google Scholar
• Tang C, Liu P, Zhou Y, et al. Sirt6 deletion in hepatocytes increases insulin sensitivity of female mice by enhancing ERα expression. J Cell Physiol. 2019;234(10):18615–18625.
   PubMed Web of Science ®Google Scholar
• Xue Z, Lui VWY, Li Y, et al. Therapeutic evaluation of palbociclib and its compatibility with other chemotherapies for primary and recurrent nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2020;39(1):262.
   PubMed Web of Science ®Google Scholar
• Xie L, Shi F, Li Y, et al. Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. Signal Transduct Target Ther. 2020;5(1):56.
   PubMed Web of Science ®Google Scholar
• Wei F, Jiang X, Gao HY, et al. Liquiritin induces apoptosis and autophagy in cisplatin (DDP)-resistant gastric cancer cells in vitro and xenograft nude mice in vivo. Int J Oncol. 2017;51:1383–1394.
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen Z, Wang X, et al. Long non-coding RNA: a new player in cancer. J Hematol Oncol. 2013;6(1):37.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Liu Z, Sun M, Lu K, et al. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression. PLoS One. 2013;8:e77293.
   PubMed Web of Science ®Google Scholar
• Yan J, Dang Y, Liu S, et al. LncRNA HOTAIR promotes cisplatin resistance in gastric cancer by targeting miR-126 to activate the PI3K/AKT/MRP1 genes. Tumour Biol. 2016;37(12):16345–16355.
   Google Scholar
• Port M, Glaesener S, Ruf C, et al. Micro-RNA expression in cisplatin resistant germ cell tumor cell lines. Mol Cancer. 2011;10(1):52.
   PubMedGoogle Scholar
• Li J, Wang Y, Song Y, et al. miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells. Mol Cancer. 2014;13(1):193.
   PubMedGoogle Scholar
• Shi L, Yin W, Zhang Z, et al. Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1. FEBS Open Bio. 2016;6(12):1211–1219.
   PubMed Web of Science ®Google Scholar
• Zhi F Zhou, G, and Shao, N, et al. miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK. PLoS One. 2013;8(8):e72390.
   PubMed Web of Science ®Google Scholar
• He QY Wang, G, and Zhang, H, et al. miR-106a-5p suppresses the proliferation, migration, and invasion of osteosarcoma cells by targeting HMGA2. DNA Cell Biol. 2016;35:506–520.
   PubMed Web of Science ®Google Scholar